First look, based on manufacturer specifications. I have not used this product. There are no scores on this page and there will not be until I have. What follows is what the manufacturer and the regulator publish about ZYN Cool Mint 3 mg, and what I think it is reasonable to infer from that — nothing more.
Cool Mint at 3 mg is the entry point to the best-distributed nicotine pouch range in the United States, and it is very likely the single most-bought pouch SKU in the country. It is also one of the few pouch products that is unambiguously legal to sell there, which is a lower bar than it sounds and a large part of why it matters.
Specifications
| Specification | Value | Source |
|---|---|---|
| Product name | ZYN Cool Mint 3 mg | FDA authorised list |
| Manufacturer | Swedish Match USA, Inc. | FDA authorised list |
| Nicotine per pouch | 3 mg | Manufacturer |
| Pouches per can | 15 | Manufacturer |
| Flavour description | “An icy burst of invigorating mint flavor” | Manufacturer |
| Stated wear time | “Up to one hour” | Manufacturer |
| Nicotine source | Nicotine salt (nicotine bitartrate dihydrate) | Manufacturer |
| Other ingredients | Hydroxypropyl cellulose (stabiliser); microcrystalline cellulose, maltitol, gum arabic (fillers); sodium carbonate, sodium bicarbonate (pH adjusters); acesulfame K (sweetener) | Manufacturer |
| US regulatory status | FDA marketing order; on the authorised pouch list current as of 21 August 2026 | FDA |
| Modified risk order | Yes — granted 30 June 2026, five-year term | FDA |
| Sibling strengths | Cool Mint 6 mg; ZYN ULTRA at 9 mg and 11 mg in other flavours | FDA authorised list |
What the specification actually tells you
Three things stand out, and none of them are about taste.
The ingredient list is short and it contains no tobacco leaf. Seven functional ingredients plus nicotine: a cellulose stabiliser, three fillers, two pH adjusters and one sweetener. There is no humectant and no added moisture in the list, which is consistent with ZYN’s dry-pouch construction and with the long stated wear time. FDA nonetheless regulates pouches as tobacco products under the Federal Food, Drug, and Cosmetic Act, and “tobacco-free” describes the leaf, not the regulatory category and not the risk.
The pH adjusters are the part worth understanding. Sodium carbonate and bicarbonate raise the pH of the pouch, which shifts nicotine towards its free-base form and makes more of it available for absorption through the mouth lining. This is why milligrams on a can are a poor guide on their own: a 3 mg pouch formulated at a higher pH can deliver more than a 3 mg pouch formulated at a lower one. Manufacturers do not publish pouch pH, so nobody outside the lab can compare two products on that basis. Our guide to pouch strengths goes into this properly.
Fifteen pouches per can is the standard ZYN format, not the twenty you get in a ZYN ULTRA can. That matters for cost-per-pouch comparisons, which are the only price comparisons worth making in this category.
Where the 3 mg sits
Swedish Match publishes 3 mg and 6 mg as the two standard strengths and offers no guidance on which suits whom, so any positioning here is inference rather than manufacturer claim. What can be said flatly is arithmetic: the 3 mg is half the nicotine of the 6 mg in the same flavour and the same format, and roughly a quarter of an 11 mg ULTRA pouch. It is the lowest strength that carries an FDA order in the ZYN range — the manufacturer’s US site currently advertises a 1.5 mg Cool Mint, but no 1.5 mg ZYN product appears on FDA’s authorised list, and I am not treating a marketing page as evidence that a product may lawfully be sold.
The same discrepancy runs through the flavour line-up. ZYN’s US site lists thirteen flavours at 3 mg, including Black Cherry, Peach and Dragonberry; FDA’s list has ten. I report both as published and draw no conclusion about the gap.
What the regulator has said, exactly
ZYN is one of the very few nicotine products in any category to hold a modified risk order, and the wording of it is narrow and specific:
“Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.”
US Food and Drug Administration, FDA Authorizes 20 ZYN Nicotine Pouches to Be Marketed with Specific Modified Risk Claim, 30 June 2026
Read what that sentence does and does not say. It is a comparison against cigarettes on six named diseases. It is not a statement that the product is safe, it is not a cessation authorisation, and FDA says in the same announcement that there is no safe tobacco product and that stopping completely is the healthiest course. The order lasts five years and can be withdrawn — FDA names youth uptake as a reason it would. When FDA authorised the twenty ZYN products in the first place, on 16 January 2025, it stated that authorisation “does not mean these tobacco products are safe, nor are they ‘FDA approved.'”
What I can say, and what I cannot
What the specification supports: a dry pouch with a simple, published ingredient list; the lowest FDA-authorised nicotine level in the range, which is the sensible starting point for anyone new to the format; the widest retail distribution of any pouch in the US; and a clear, verifiable legal status, which very few competing products have.
What it does not support, and what this page will not tell you: how strong it actually feels, how fast the nicotine arrives, whether the mint reads as cooling or as sweet, how much the pouch runs, how it sits under the lip, whether the flavour holds for the full hour the manufacturer claims, or how it compares on any of that to on! PLUS Mint or to the 6 mg. Those are test-session questions and I have not run one. Anyone publishing numbers for them off a spec sheet is making them up.
Alternatives worth knowing about
Because the authorised list is only 43 products from two companies, the genuine alternatives in the US are unusually easy to enumerate. At or below this nicotine level the options are on! at 2 mg (Autumn Spice, Cappuccino, Rich Berry) and the other nine ZYN flavours at 3 mg. Step up and you have Cool Mint 6 mg, on! PLUS at 6 mg in Mint, Tobacco or Wintergreen, and the ULTRA tier at 9 mg and 11 mg. Everything else marketed in the US sits outside FDA’s list. The master ranking covers the wider field, and the flavour guide covers what mint variants generally differ on.
What would change this page
A test session. When I have used this product across enough sittings to say something about onset, strength perception, flavour duration and pouch feel, this page gets rewritten with the full six-score verdict and a pros-and-cons block, and the first-look label comes off. Until then it stays as it is. Our ZYN Wintergreen 6 mg page carries the same caveat for the same reason.
Sources
- FDA — Nicotine Pouch Products Authorized by the FDA, current as of 21 August 2026
- FDA — authorised nicotine pouch product list (PDF)
- FDA — modified risk order for 20 ZYN products, 30 June 2026
- FDA — marketing authorisation for 20 ZYN products, 16 January 2025
- Swedish Match USA — ZYN product FAQ (ingredients, pouches per can, wear time)
- Swedish Match USA — ZYN Cool Mint product page
Last verified: 22 September 2026.
Nicotine is addictive. No tobacco or nicotine product is safe, and completely stopping is the lowest-risk option. This site is for adults who already use nicotine — 21+ in the United States, 18+ or your local legal age elsewhere. Nothing here is medical advice.